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Abstract
People living with heart failure (PLHF) should be screened for symptoms at every
healthcare visit since they are 3 times more likely to experience ventricular arrhythmias.
This quality improvement project (QIP) compared 3 self-administered HF symptoms
questionnaires to determine the best screening tool for a tertiary hospital arrhythmia
devices clinic. The instruments included the Minnesota Living with Heart Failure
Questionnaire (MLHFQ), the Kansas City Cardiomyopathy Questionnaire (KCCQ), and
the Self-Reported Heart Failure Symptoms (SHEFS) questionnaire. For a 30-day period,
76 people were eligible to participate in the QIP, with 55 participants included in the final
analysis (72.5% participation). The questionnaires were compared and assessed with the
gold standard laboratory test for HF (NT-proBNP) for sensitivity and specificity. For HF,
the SHEFS was the most sensitive (83%) compared to the NT-proBNP, but the MLHFQ
was most specific (89%). When compared to the MLHFQ as the standard, SHEFS was
71% sensitive, and 73% specific for HF. Similarly, when compared to the KCCQ, the
SHEFS was both, 75% specific and sensitive in identifying HF. However, the rate of
correlation to a positive or negative NT-proBNP test results was the highest for the
SHEFS (87%). All 3 questionnaires were statistically significant in predicting admission
to hospital for HF in the past 6 months (p = 0.02 to 0.03). Finally, given the shortest
length and simplicity of use, the SHEFS was selected by the stakeholders to be the
standard screening tool for the clinic. This project contributes to positive social change by
providing the first reported comparison in the literature to implement questionnaires in a
clinic to assess symptoms for PLHF attending an arrhythmia devices clinic.
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Section 1: Nature of the Project
Introduction
Heart failure is a chronic, progressive disease with unpredictable and fluctuating
stages and cycles of exacerbation. According to Centers for Disease Control and
Prevention (2016), there are close to 6 million adults in the United States living with
heart failure. Approximately one in four heart failure patients die within one year and
50% die within five years of initial diagnosis (Gerber et al., 2015). In the United States,
approximately $40 billion is spent each year on caring for people living with heart failure
(PLWHF) (Lloyd-Jones et al., 2010).
The increased risk for life threatening cardiac arrhythmias is an important heart
failure complication (van Riet et al., 2016). Arrhythmias result from the left ventricular
dysfunction (LVD) diagnosed in the more than 40% of PLWHF (van Riet et al., 2016).
The ventricular arrhythmias are highest amongst people with LVD accompanied by a low
ejection fraction (EF) (40% or less) (Buxton et al., 2002). In this subgroup of patients, an
implantable cardiac device (ICD) is recommended to prevent cardiac arrest from the
ventricular arrhythmias (Bennett et al., 2016). With an ICD, PLWHF require routine
monitoring and maintenance in a specialty arrhythmia devices clinic. The purpose of this
quality improvement project was to identify an effective screening tool for self-reported
symptoms of heart failure in order to efficiently recognize those who are at an increased
risk of experiencing a cardiac arrest due to ventricular arrhythmia.
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Problem Statement
Local Context for Gap-in-Practice
The Arrhythmia Devices Clinic (ADC) is an outpatient clinic, located in an
ambulatory center of a large tertiary hospital in southwestern Ontario. The ADC is
responsible for the continued care of PLWHF who have an ICD as a result of
experiencing an episode of ventricular arrhythmia, or because they are at risk for
developing an arrhythmia. Within the ADC, there is a robust quality management
program focused on assurance, control, and improvement. The arrhythmia program
database is an important source of information for the ADC quality management
program, and which guided this project.
At each cardiac related appointment, both the Heart Failure Society of America
(HFSA), and the Canadian Cardiovascular Society (CCS) recommend a routine heart
failure assessment for all people with history of heart failure or who are at risk for
developing heart failure (Lindenfeld et al., 2010; Moe et al., 2015). This assessment
includes review of signs and symptoms of heart failure such as orthopnea, paroxysmal
nocturnal dyspnea, shortness of breath on exertion, and peripheral edema (Mayo Clinic,
2017a). These assessments are especially important for people with a documented history
of heart failure, and/or those who are at risk of developing heart failure (Lindenfeld et al.,
2010; Moe et al., 2015). Despite the importance of this assessment, practice in the ADC
did not involve the element of evaluating patients for signs and symptoms of heart
failure. As such, the missed opportunity to identify a patient at risk contributed to
suboptimal care.
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Local Relevance and Practice Environment
A recent review of the arrhythmia program database revealed that close to 15% of
patients who are being followed in the ADC are admitted, or readmitted to hospital
annually with the diagnosis of heart failure or ventricular arrhythmias. As such,
management of heart failure in the ADC was identified as one of the leading problems in
need of addressing through a quality improvement project; an implementation of a heart
failure screening tool.
Although there are currently seven validated heart failure screening tools
available in the literature (Dunderdale et al., 2008; Guyatt et al., 1989; Hak et al., 2004;
Mannheimer et al., 2007; O’Leary et al., 2000; Spertus et al., 2015; Wiklund et al., 1987),
none have been evaluated for use in an arrhythmia clinic setting (Garin et al., 2013; Garin
et al., 2014) (Appendix A). As such, the validated tools needed to be evaluated for their
sensitivity and specificity, as well as usability and usefulness, in identifying heart failure
symptoms in arrhythmia clinic setting.
Significance and Implications for Nursing Practice
Given the compelling link between heart failure and arrhythmia, the need to
identify an evidence-based screening tool for heart failure that is easy to use, and
provides useful data in the arrhythmia clinic setting, was important to optimize patient
care, and improve overall health outcomes. Nurses play an integral role in patient care
and often represent the first and/or only encounter of the patient with the healthcare
system. As such, optimization of care depends largely and completely on these
opportunistic encounters. By implementing a heart failure screening instrument that is
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feasible, suitable, and applicable to the ADC practice environment, would ensure that the
nurses have the appropriate tools to optimize care, and improve patient outcomes.
Purpose Statement and Project Objectives
Gap-in-Practice Defined
The purpose of this evidence-based quality improvement project, or EB-QIP, was
to identify the most relevant heart failure screening instrument, evaluate the instrument
validity, reliability, and applicability to the population, and then recommend the best
instrument for the arrhythmia clinic. Previously, patients presenting to the ADC were not
screened, assessed, and/or managed for heart failure. The project objective was to
identify an evidence-based quality improvement tool that would increase health care
provider’s awareness, knowledge, and use of evidence-based guidelines in the
management of heart failure.
Evidence-Based Practice
Evidence-based health care combines current knowledge, up-to-date research, and
expert advice in order to provide care that is consistent, effective, and efficient. Hanson et
al. (2012) described how utilizing evidence-based guidelines in clinical practice led to a
significant decrease in venous thromboembolic events in children after trauma. Similarly,
a study done by Kudenchuk et al. (2012) showed how the use of evidence-based
guidelines contributed to improved outcomes in patients who suffered an out of hospital
arrest. Lastly, Farmakis et al. (2016) demonstrated how a substantial decrease in
mortality from heart failure was achieved when evidence-based guidelines for heart
failure were incorporated into the care process.
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In order implement, promote, and ensure evidence-based practice, the research
question to guide the practice must be first clearly defined. In this case, this was
accomplished by utilizing the PICOT method: P (patient population/problem/place), I
(intervention/test), C (comparison/current practice), O (outcomes), and T (type of
project/time). Therefore, using the PICOT format, the research question was initially
formulated as follows: In the population attending an outpatient ADC, which of three
(two of which are evidence-based, and one of which was developed specifically for the
project) self- administered heart failure symptoms instruments could best identify heart
failure patients at risk for ventricular arrhythmia? The three instruments evaluated
included: (a) Self-reported Heart Failure Symptoms (SHEFS) questionnaire (Appendix
B), (b), Minnesota Living with Heart Failure Questionnaire (MLHFQ) (Appendix C), and
(c) Kansas City Cardiomyopathy Questionnaire (KCCQ) (Appendix D).
PICOT Process
In order to ensure the best patient outcomes, nurses need to incorporate the latest
evidence in their clinical practice (Barth et al., 2016). This is an ongoing quality
improvement process beginning with a structured question to define a clinical problem,
called the PICOT question (Melnyk et al., 2011). This PICOT question is derived from a
well described method to guide nurses in defining a clinical problem, organizing the facts
into a clear and concise problem statement, identifying the best research evidence, and
evaluating the evidence for implementation into practice. The evidence is evaluated to
determine what interventions work the best, in what kind of clinical setting, and for what
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patient population. This method informed the development of the PICOT question that
guided this project.
PICOT Question
P-Patient/Population/Problem/Place
Adult patients (age 18 or older) with a Cardiac Resynchronization TherapyDefibrillator (CRT-D) or a Cardiac Resynchronization Therapy-Pacemaker (CRT-P).
Problem: There was no screening being done or documented for heart failure symptoms
in patients attending the ADC. Existing screening questionnaires are complex and time
consuming. Place: Outpatient, ambulatory ADC located in a tertiary hospital in
southwestern Ontario
I-Intervention
The SHEFS instrument; the MLHFQ and the KCCQ instruments.
C-Comparison
Current standard, no instrument.
O-Outcomes Measured
The primary outcome for this project was the fit (or lack of fit) of the screening
instruments for the clinical setting. Also, the sensitivity for identifying heart failure was
evaluated. Secondary outcomes included a review of the rates of healthcare providers
documenting the questionnaire findings in the patients’ charts. Finally, the rates of
readmission to hospital with symptoms of heart failure and/or ventricular arrhythmias
requiring shock from the device will be evaluated after the recommended screening tool
has been implemented.
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T-Type of Project/Time
A quality improvement project with instrument evaluation. The quality
improvement project was implemented over a period of one month. In addition, in order
to evaluate the instrument's fit and suitability from a users’ perspective, the Delphi
method was employed.
Response to the Gap-in-Practice
The quality improvement project highlighted the need for healthcare providers to
use evidence in the treatment of heart failure in the ADC setting. Secondly, by identifying
and recommending a heart failure screening instrument that is most suitable for the ADC,
this project represented the first step in changing practice behaviors.
Nature of the Doctoral Project
Project Sources of Evidence
A recent review of the Planning and Analysis EP Database (unpublished,
confidential ADC document) indicated that approximately 15% of readmissions to the
hospital for patients with an implantable device are due to heart failure exacerbations, and
heart failure related ventricular arrhythmias. The current practice in the ADC does not
include screening, assessment, treatment, or documentation of patient’s signs and
symptoms of heart failure.
As PLWHF are at threefold the risk of developing ventricular arrhythmias, this
was an important identified gap in practice that needed to be addressed (Cubbon et al.,
2016).
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This quality improvement project proposed to establish a standardized operating
procedure to effectively identify PLWHF seeking care at the ADC who are either at risk,
or who are currently exhibiting heart failure signs and symptoms. The project endeavored
to classify the existing heart failure screening tools as to their relevance, fit, applicability,
and usability in this specialized clinical setting. Previously, there has been limited
evidence as to the application of the existing heart failure screening tools within an
outpatient clinic setting.
Project Method
Seven well-known and used instruments were identified in the literature; these
were narrowed to the two most relevant for this project (Appendix A). Then, these two
instruments were administered to measure the self-reported heart failure symptoms for
the defined patient population. In addition, a new proposed heart failure screening tool
developed especially for the clinic was administered alongside the validated tools for the
purpose of comparison. Once this project data was collected and evaluated, a
recommendation, as to the most appropriate tool, was presented to the stakeholders. Once
the stakeholders selected an instrument, a policy and procedure with an education module
will be developed to implement the instrument in the ADC.
Project Pathway
The purpose of this doctoral project was to trial three different heart failure
screening tools (two validated tools, and one newly developed tool) in the ADC setting,
and identify the tool that would be most appropriate for being used in the clinic
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environment. The best tool was then recommended for implementation in the care
process.
Significance of the Project
Statistical Evidence
With more than one million people hospitalized throughout the United States and
Europe, heart failure is a global pandemic (Ambrosy et al., 2014). According to Dunay et
al. (2014) about $70 billion will be spent annually on heart failure care by the year 2030.
This expenditure can be reduced with wide spread implementation of the appropriate,
relevant, and evidence based processes to aid in the early recognition and management of
heart failure. For example, Farmakis et al. (2016) demonstrated how optimizing heart
failure care through evidence-based recommendations significantly reduced morbidity
and mortality from the disease.
The progressive pathology of heart failure eventually leads to left ventricular
dysfunction (Gerber et al., 2015), which results ultimately in electrical conduction
abnormalities such as ventricular arrhythmias (van Riet et al., 2006). To treat these lifethreating conduction abnormalities, an implantable cardiac device is recommended
(Beyerbach, 2016). Overall, early interventions can decrease the number and the severity
of ventricular arrhythmias linked to the disease (Cubbon et al., 2016).
Stakeholder Analysis
The stakeholder analysis was important for this quality improvement project to
identify all of the parties that could potentially affect or be affected by the project and/or
project outcomes. (Hodges & Videto, 2011). The topic for this project was
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collaboratively selected by the clinical director, medical director, clinical manager, and
the project leader. Subsequently, additional stakeholders were identified and invited to
participate in the development of the SHEFS questionnaire. The purpose behind the
development of the SHEFS questionnaire, was to create a simple tool that would allow
for a quick assessment of heart failure symptoms in the clinic setting, given the limited
current resources. The additional stakeholders included arrhythmia physicians, clinical
educator, nurse clinicians, clinical nurse specialist, cardio vascular technologists, and
business clerks. Furthermore, the entire stakeholder group was invited to contribute to the
project design and the implementation strategy. The project stakeholders were identified
through personal conversations, program meetings’ discussions, and formal and informal
electronic mail announcements.
Stakeholders are considered to be those individuals that could affect or be affected
by decisions, behaviors, or actions related to provision of care. This project embraced the
involvement of the stakeholders as a critical source of knowledge specific to improving
disease management. Kountz et al. (2015) argued that enhancements to patient care
require a multidimensional approach, including the involvement of diversified
stakeholders. Through an analysis, the authors found three main stakeholder groups: (a)
patients, (b) healthcare providers, and (c) payers. For example, the study done by
Haywood et al. (2014) demonstrated how health-related quality of life, and patient
reported outcomes influenced, and were influenced by, the stakeholders: patients and the
general public.
Contributions to Nursing Practice
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The purpose of the project was to create awareness among healthcare providers of
the importance, relevance, and effects of evidence-based heart failure screening.
Secondly, the project contributed to a meaningful modification of the arrhythmia clinic
nurses’ attitudes, beliefs, and behavior patterns with respect to screening for heart failure,
and generated practice that will include consistent use of evidence-based heart failure
screening. Finally, the project enabled and supported the nurses in consistently applying
evidence in their practice.
Within the ADC setting, the role of nursing should encompass a routine
interrogation of the implantable device, review and reconciliation of medications, vital
signs measurement, and focused physical assessment of the patient. However, in majority
of the cases, only the first two activities were completed (i.e. vital signs are not checked,
and physical assessment is not performed). These omissions resulted in missed
opportunities in identifying heart failure signs and symptoms. The nurses reported that
time constraints, absence of management support, lack of knowledge of evidence-based
guidelines, and overall lack of comfort in dealing with heart failure were the main
barriers. However, as Saunders and Vehvilainen-Julkunen (2016) contended, nurses are
optimally positioned to apply the best evidence to their clinical practice because of their
skills, knowledge, experience, and nature of their roles. The nurses often represent the
first, and sometimes the only healthcare encounter between the patient and healthcare
agency. As such, nurses are best positioned to change practices and revise processes to
optimize patient care.
Transferability of Knowledge
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Knowledge transfer is the process of sharing, communicating, spreading, or
diffusing knowledge (theoretical or practical) to other individuals within the organization.
The purpose of knowledge transfer is to ensure that all those involved have access to this
knowledge of information, data, and results in order to establish full understanding of the
issue(s) at hand, and to promote optimal collaboration. Singh et al. (2015) demonstrated
how knowledge transfer approach resulted in an effective implementation and
dissemination of best practice guidelines for stroke, and ultimately, in improved patient
care and outcomes. The authors utilized a unit-based knowledge transfer team approach
to champion and encourage the use of evidence-based guidelines through bedside
mentoring, informal discussions, and collaborative patient care.
Firstly, the knowledge developed by the stakeholders specific to quality
improvement and evidence-based practice will be used for other projects within the ADC.
Secondly, the knowledge obtained from the project implementation and evaluation has
the potential of being applied in similar settings within the organization, as well as to
other arrhythmia clinics in the region, province, and country. Finally, this knowledge will
contribute to the development of new guidelines and protocols, and inform changes in
practices.
Implication for Positive Social Change
Social change can be best described as any meaningful and considerable
modification of behavior patterns, attitudes, and opinions, resulting in substantial social
consequences or outcomes (Form & Wilterdink, 2017). For example, a systematic review
and meta-analysis done by Laranjo et al. (2014) demonstrated that implementing
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interventions through social networking sites resulted in significant positive effects on
health behavior-related outcomes.
Implementation of a feasible, applicable, and sustainable screening tool for heart
failure symptoms in outpatient, ambulatory arrhythmia clinic patient population, will
allow in the future for a consistent, comprehensive, and evidence-based assessment of
patients for heart failure symptoms. This in turn will enable healthcare providers in early
identification of the disease, initiation of appropriate interventions and follow up, and
avoidance of hospital admission. Consequently, this will result in improved quality of life
for the patient as well as a decrease in the risk of adverse events.
Summary
In summary, heart failure care continues to contribute to a significant economic
and psychosocial burden. The magnitude of the problem will likely continue to rise as the
population ages, and more individuals are diagnosed with heart failure. One of the
fundamental solutions to this problem, is to implement standardized, consistent, and
evidence-based processes and methods to enable an early recognition of the disease and
hence, an early treatment. A recent evaluation of the ADC environment revealed that no
such screening was being done, and since a significant portion of ventricular arrhythmias
is the direct result of heart failure, screening for symptoms of the disease should be an
expected and integral component of clinic assessment.
In the following section of this paper, an evidence-based practice model was
defined, and the process of applying the model’s concepts to develop and implement
interventions addressing the above issue, was described. Background to the problem was
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discussed within the context of the clinical setting, and the problem’s relevance to
nursing practice was explained. Finally, the role of the project leader in this quality
improvement project was explored, followed by a short synopsis of the research
literature.
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Section 2: Review of Scholarly Evidence
Introduction
Despite the fact that patients with heart failure are at higher risk of developing
ventricular arrhythmias, previous practice in the ADC did not include the assessment of
patients for signs and symptoms of heart failure (van Riet et al., 2016). As such, the
purpose of this quality improvement project was to identify an effective screening tool
for self-reported symptoms of heart failure in order to efficiently recognize those who are
at an increased risk of experiencing a cardiac arrest due to ventricular arrhythmia. In this
section of the paper, the evidence-based model used to guide this project will be
described, the project’s relevance to nursing practice will be discussed, local background
and context in which this project was developed will be examined, and the role of the
DNP student will be outlined.
Theories, Models, and Concepts
According to Schaffer, Sandau, and Diedrick (2012), evidence-based practice
(EBP) models assist in translating research evidence into clinical practice (Schaffer et
al., 2012). Complexity of the practice problem as well as the nature of the clinical setting
in which the problem is present will determine model suitability. Although there are a
number of applicable EBP models available in the literature, the Stetler’s model of
evidence-based practice guided this project (Stetler, 2001).
Stetler Model of Research Utilization
Since 1976, the Stetler model of evidence-based practice has been renamed the
Stetler model of research utilization (Stetler, 1994). According to Stetler, this model is
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based on the assumption that the individual’s use of research may or may not involve the
formal organization and secondly, that lack of knowledge and skills related to the use of
research can impede effectiveness of its use (National Collaborating Centre for Methods
and Tools, 2011).
The model also outlines some criteria to first establish if the project/program is
desirable and feasible. These criteria include: level of corroborating evidence, current
practice and magnitude of need for change, suitability for the project/program in the
specific clinical setting, and the feasibility of implementing the program based on
availability of human and financial resources, risks and benefits, and readiness of the
stakeholders (Stetler, 2001).
Stetler’s evidence-based practice model is comprised of five phases or stages to
guide clinicians through the process of applying research findings in clinical practice.
These phases include: (a) preparation, (b) validation, (c) comparative
evaluation/decision making, (d) translation/application, and (e) evaluation. The Stetler’s
model is appropriate for this quality improvement project as it mimics the five phases
through: (a) preparation of the screening instruments, (b) validation of the instruments,
(c) evaluation of suitability for the ADC, (d) application of results/knowledge, and (e)
evaluation of outcomes.
The first phase of the model includes identification of the problem at hand,
exploring all influencing factors that may contribute to the issue, and evaluating
available and current research on the topic. In the second phase of the model, the
available evidence is evaluated for credibility and relevance to the stated problem. Third
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phase of the model includes the process of summarizing research findings and
formulating recommendations. Translation of evidence into practice, including the
incorporation of any specific or required variations, makes up the fourth phase. In the
fifth and final phase of the model, implementation outcomes are evaluated, and
relevance to practice is outlined. The following paragraphs will describe how the
model’s phases were completed throughout the Project.
The first phase of Stetler’s model is designed to help the health care provider in
identifying the need for change, or the need to solve a clinical problem, in the context of
available and relevant evidence. In the case of the project, a review of the program’s
2015 organizational data revealed that a significant portion of the ADC patients were
readmitted to the hospital within 30 days of their device implantation. Majority of these
readmissions were related to heart failure, and heart failure related ventricular
arrhythmias. As part of quality improvement, the need to improve heart failure care
within the clinic was identified. The specific characteristics of the clinic’s environment
and staff were explored in order to assess any potential influencing factors that may
influence or hinder implementation of practice change, such as lack or limited financial,
physical, or human resources.
In the second, or validation phase, each of the available sources of evidence were
evaluated for credibility, relevance, and level of strength. The sources of evidence
included program specific database, organizational statistics, peer hospitals, evidencebased guideline depositories, and research literature. The relationship between heart
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failure screening in the ADC, and the potential decrease in the rates of re-admissions for
this patient population was established.
The third phase of Stetler’s model involved the process of organizing the
evidence, summarizing findings, and making recommendations. The result or end
product of this phase was the recommendation that a screening tool for heart failure
should be implemented within the ADC. The decision was made to trial three different
tools: one developed specifically for the clinic, and two other tools that were previously
applied in other settings.
During the fourth, or translation phase of the model, the screening tools were
evaluated as to their fit and applicability, and a formal plan for practice change was
formulated.
Finally, the fifth or evaluation phase of the model evaluated if proposed change
was efficient and effective, and what type of strategies needed to be implemented in
order for the change to be sustained.
Project Relevance to Nursing Practice
Search Strategy
Literature search was conducted using the following databases: Cochrane
Systematic Reviews, MEDLINE (PubMed), CINAHL, Psych Info, Google Scholar, and
Embase. The key words included in the search were as follows: heart failure, guidelines,
CRTs, outpatients, screening tools, ventricular arrhythmias, and self-reported (all MeSH
terms). Only articles available in the English language were assessed and/or included in
the literature review for the project. All abstracts yielded from the initial search were
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reviewed before being considered for further examination and subsequent appraisal.
Those articles deemed relevant to the project were included in the final analysis.
Literature search was limited to articles from the year 2006 to 2016, unless they
contributed to further knowledge and understanding of the issue at hand, such as original
source articles.
In total, 99619 articles were initially identified when the search terms heart
failure and screening tools were used. The articles were narrowed down to 1495 when
the above terms were used in combination with self-administered. These were further
narrowed down to 132 articles when the term outpatients was added. Abstracts of all of
the 132 articles were reviewed, and subsequently 12 articles were considered for the
project’s literature review. Summary of the articles is presented in Appendix F with
levels of evidence in Appendix G.
General Literature
There is ample evidence in the literature on the use of heart failure screening tools
in inpatient settings (Garin et al., 2014; Green et al., 2000; Spertus et al., 2015) or in
outpatient cardiology clinic settings (Eurich et al., 2006; Gilbert et al., 2015; Heidenreich
et al. 2006; Masoudi et al., 2004). However, there is a limited evidence as to the use of
the existing heart failure screening tools within an ambulatory arrhythmia clinic setting.
The purpose of this project was to classify the existing heart failure screening
tools/questionnaires as to their relevance, fit, applicability, and usability in the specialized
clinical setting by the nursing staff. Since nurses represent the initial and most often the
only contact of the arrhythmia patients with a healthcare provider during their clinic visit,
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it is essential that screening for heart failure be completed by the nursing staff. Through
their knowledge, skill, and expertise, and through the use of appropriate and relevant
screening tool, nurses will be in a position to provide optimal patient care to the ADC
patient population.
Heart failure is associated with a high morbidity and mortality rate with
approximately 50% of individuals dying of the disease within five years of diagnosis, and
25% dying within one year (Gerber et al., 2015). Those who were previously hospitalized
for decompensated heart failure, are at significantly higher risk of recurrent events
including death (Senni et al. 2014). Due to the frequent episodes of hospitalizations and
re-hospitalizations required as a result of the disease, the economic burden of heart failure
care is staggering. In 2012, the global annual cost of direct and indirect heart failure care
was estimated to be nearly 108 billion dollars (Cook et al. 2014). In the United States
specifically, this cost was assessed to be at over 30 million. In that same year, Canada
spent close to four million on costs associated with heart failure.
The pathophysiology of heart failure contributes to left ventricular remodeling,
which leads to abnormalities in the function and structure of the heart predisposing it to
life-threatening arrhythmias (Jaeger, 2010). According to Jaeger, cardiac arrhythmias
stemming from severe left ventricular dysfunction have the potential of resulting in
sudden death. As a result, these patients most often have an implantable cardiac device
inserted for primary prevention. In the case of ongoing heart failure symptoms and
depressed left ventricular function, patients receive a device capable of cardiac
resynchronization as well. Despite the available mechanical therapy, the goal of
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optimizing heart failure, and decreasing the likelihood of ventricular arrhythmias, is to
optimize medical therapy as per evidence-based guidelines.
Specific Literature
Guyatt (1993) argued that health-related quality of life could be measured
through either a generic or a disease-specific instrument or both, as they are not
mutually exclusive. The author described how each of these instruments has its strengths
and weaknesses, and how one may be better over another depending on the setting
and/or circumstances. Guyatt contended that the key measurement properties of an
instrument were its ability to detect crucial changes (responsiveness), and its ability to
measure what it was assumed to measure (validity).
Berry and McMurray (1999) reviewed the design and validation of a number of
general and disease-specific questionnaires, and their performance in measuring quality
of life in patients with heart failure. The authors contended that in order for any
questionnaire to be useful, it must be able to assess the patient’s physical, emotional as
well as social status or wellbeing. Furthermore, disease-specific questionnaires, rather
than generic questionnaires, provided more useful information when the effects of
treatment were being measured.
Similarly, Eurich et al. (2006) looked at the responsiveness of both generic and
heart failure specific questionnaires to assess change over a period of six weeks. The
responsiveness was measured in terms of psychometric indices as well as outside
clinical data. The authors concluded that the Kansas City Cardiomyopathy Questionnaire
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(KCCQ) was the most responsive tool when attempting to assess change over a short
period of time.
Garin et al. (2009) completed a systematic review with meta-analysis to evaluate
heart failure specific quality of life instruments on their reliability, validity, and
responsiveness. The following instruments were included in the review: Minnesota
Living with Heart Failure Questionnaire (MLHFQ), Chronic Heart Failure
Questionnaire (CHFQ), Quality of Life Questionnaire for Severe Heart Failure (QLQSHF), Kansas City Cardiomyopathy Questionnaire (KCCQ), and Left Ventricular
Dysfunction (LVD-36) questionnaire. Garin concluded that the evidence showed most
support for the use of MLHFQ, followed by KCCQ, and then CHFQ.
Then, five years later, Garin et al. (2014) conducted another systematic review to
assess heart failure specific questionnaires. The authors identified seven such
questionnaires, and evaluated them for reliability, validity, sensitivity to change, and
interpretability. Overall, the authors rated the KCCQ as their first choice, followed by
the MLHFQ, and the CHFQ.
Finally, Kelkar et al. (2016) conducted a systematic review on the existing
patient-reported outcomes tools for heart failure. Out of 31 instruments identified in the
literature, nine met the authors’ initial inclusion criteria. Kelkar further assessed these
nine instruments with respect to their psychometric indices and relevance to clinical
practice. The authors concluded that only two out of the nine tools met all criteria:
MLHFQ and the KCCQ.
Evidence to Address the Gap-in-Practice
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Despite the overwhelming evidence in the literature that evidence-based
guidelines contribute to an enhanced patient care and improved outcomes, guideline
recommended therapies are often poorly followed by the healthcare providers. A
systematic meta-analysis done by Gohler et al. (2006) reported that guideline suggested
heart failure medications were prescribed by the providers on average 60% of the time
and in as low as 10% of the cases. Although many studies in the literature define
adherence as 80% compliance with recommended therapies, Vehovec et al. (2016)
showed that rates higher than 80% were required to reduce the risk of death in heart
failure patients.
Local Background and Context
Evidence to Justify the Problem
A recent review of the planning and analysis EP Database (an unpublished and
confidential document developed as part of a quality improvement project for the
hospital) identified that about 15% of the AP patients are re-hospitalized within 30 days
of having their implantable device inserted. Although a number of causes for the
readmissions were identified, heart failure constituted to be the main reason, followed by
episodes of ventricular arrhythmias.
By implementing best practice within the ADC, the arrhythmia program will
contribute to providing the best care for its patients while advancing healthcare through
education and research. Furthermore, improving heart failure care within the ADC, will
likely result in decreased rates of readmission to hospital, and heart failure related
complications.
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Institutional Context
The ADC is situated within a large tertiary hospital located in southwestern
Ontario, Canada. The clinic is part of the arrhythmia program (AP) whose mandate is to
provide assessment, treatment, and follow up care of patients with cardiac arrhythmias
and/or, with implantable cardiac devices. As part of the Local Integrated Health
Network, the AP is the regional referral center for patients with arrhythmias in
southwestern Ontario.
A Quality Improvement Plan (QIP) published by the hospital in 2014, identified
five strategic organizational goals, including the need to implement best practices as the
means to improve the patient experience (Hospital A, 2014). In response to the
publication, the AP stakeholder team identified heart failure care as an area for
improvement. The stakeholder team also acknowledged that any clinical project
undertaken to meet the strategic goal, had to align with the mission, vision, and values of
the organization. Through respect, caring, innovation, and accountability, the hospital’s
mission is to “provide excellent health care for the people and communities we serve
and to advance health care through education and research” (Hospital A, 2016).
Local Terms and Definitions
For the purpose of this project, the following terms were defined:
Arrhythmia Devices Clinic (ADC)
A specialized outpatient, ambulatory clinic providing care to patients who have an
implantable cardiac device.
Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
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An implantable medical device intended to synchronize the contractions of the
ventricles for optimal efficiency of the heart (Boehmer, 2004; Marzec et al., 2017). It is
also capable of delivering electrical energy through the heart when a ventricular
arrhythmia is detected by the device (Ellenbogen et al., 2016).
Cardiac Resynchronization Therapy-Pacemaker (CRT-P)
An implantable medical device intended to synchronize the contractions of the
ventricles for optimal efficiency of the heart (Boehmer, 2004; Marzec et al., 2017). It is
also capable of electrically pacing the heart if the patient’s heart rate falls below
predefined set parameters (Ellenbogen et al., 2016).
Guidelines
A set of evidence-based recommendations, developed by experts in the field, to
guide care of a specified condition/disease including assessment, diagnosis, and treatment
(National Institute for Health and Care Excellence, 2017).
Heart Failure
A condition in which the heart fails to keep up with the demands to provide
adequate blood flow to the rest of the body (Heart and Stroke Foundation of Canada,
2017). Most commonly associated with symptoms of shortness of breath, swelling of
lower extremities, and inability to lie flat (American Heart Association, 2017).
Stakeholders
Any and all individuals who could influence or could be affected by the project’s
implementation and outcomes (Hodges & Videto, 2011).
Ventricular Arrhythmia
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An abnormal rapid heart rhythm that originates in the lower chambers of the
heart. This rhythm can result from damage to the heart muscle, cardiomyopathy, or
sometimes in structurally normal hearts (Mayo Clinic, 2017b). Often associated with
sudden cardiac death (Ellenbogen et al., 2016).
Role of the DNP Student
Professional Relationship to the Project
The American Association of Colleges of Nursing (AACN) (2006), outlined the
essentials, or critical elements, that are integral to define the role and responsibilities for
graduates with the doctor of nursing practice (DNP). According to the AACN, a DNP
program prepares students to meet these foundational elements. Subsequently, this
project allowed the student to fulfill the requirements to successfully meet these
essentials. Specifically, through this project the student was able to demonstrate the use
of science to guide practice, incorporate organizational and systems leadership for
quality improvement, analyze evidence, contribute to policy development, integrate
inter-professional collaboration to improve patient outcomes, and influence population
health (AACN, 2006).
Professional Role in the Project
In the context of this evidence-based quality improvement project, the DNP
student functioned as the project leader, acting as a change agent within the healthcare
agency. Specifically, the project leader was responsible for defining a clinical practice
problem. Then, by designing, implementing, and evaluating an evidence-based quality
improvement project, the project leader improved the clinical practice. The DNP student
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had also the unique advantage of having the theoretical knowledge and the practical
experience/expertise to bridge the gap between theory and practice, and to produce and
introduce changes that would best serve the needs of the ADC population.
Motivation for Completing the Project
The DNP student’s motivation to complete this project stemmed from both a
personal and professional desire to improve the treatment of heart failure patients at all
levels of care. The student’s past work experience involved caring for patients in a heart
failure specialty clinic. During this time period, many bonds were made between the
student and the patient as well as the patient’s family members. The patients and their
loved ones often referred to the clinic as their lifeline. However, only 2% of patients
with the diagnosis of heart failure are actually followed in a specialty clinic (Howlett et
al., 2015). The remaining 98% are followed by family practitioners, cardiologists,
internists, or not at all. As such, the importance of identifying, treating, and optimizing
heart failure at any cardiac related encounter, especially in ADC setting, was extremely
high for the DNP student. By leading this change, the DNP student served as a role
model and champion for the nursing profession by demonstrating commitment to
evidence-based practice. Secondly, by implementing the DNP project, the student played
a significant role in improving patient care, optimizing clinical outcomes, and improving
efficiencies. Finally, the DNP student contributed to policy changes at all levels of care,
by developing policies, and by planning, organizing, implementing, and evaluating new
processes to improve delivery of care. This dedication to nursing profession and
evidence-based practice was one of the strongest motivators to complete this project. On
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a personal level, the DNP student’s motivation to complete the project was that of
feeling of a personal accomplishment by reaching one of the student’s long-term life
goals.
Potential Biases
This DNP student had previously worked with heart failure population and was
strongly motivated to improve the care of these patients in any setting. However, this
motivation may have been interpreted as bias towards healthcare providers who did not
think that heart failure assessment was important in the ADC setting. For example,
resistance to change in practice may be interpreted as indifference or lack of knowledge
rather than the fact that there are insufficient resources in place to sustain the change.
Another possible bias was the fact that the project included only patients who
had a CRT-D or CRT-P device, as they have a known and documented history of heart
failure (an initial indication for the implantable cardiac device). However, there may be
other patients with an implantable cardiac device such as Permanent Pace Maker (PPM)
or Implantable Cardioverter Defibrillator (ICD) who may exhibit initial or ongoing signs
and symptoms of heart failure and who did not benefit from the assessment.
Summary
The purpose of this section was to explain and define the significance of the
problem as it related to the clinical practice setting. This was accomplished by exploring
the local background behind the problem and the context within which the problem
exists. Secondly, the role of the DNP student in the project was explained and described
as it pertained to the eight essentials for the DNP practice. Following that, a brief
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literature review illustrated the scope of the problem and the need for change of the
current practice. The literature also identified two screening tools for heart failure, which
have been previously validated, and which were used for the purposes of the project:
KCCQ and MLHFQ. Finally, the Stetler’s model for evidence-based practice was
described in terms of the framework being chosen to support and guide the process of
planning, developing, implementing, and evaluating the project. The next section of this
paper will focus on outlining the study design, approach methods, data collection, and
analysis of evidence.

30
Section 3: Collection and Analysis of Evidence
Introduction
Previous practice in the ADC did not include screening for the signs and
symptoms of heart failure. This resulted in missed opportunities for optimization of care
and potential, and avoidable, admissions to hospital due to heart failure, or ventricular
arrhythmias due to exacerbation of the disease. The purpose of this evidence-based
quality improvement project was to identify the most relevant heart failure screening
instruments, evaluate the instrument validity, reliability, and applicability to the
population, and recommend the best instrument for the arrhythmia clinic. A search of
literature presented in the previous section, demonstrated that adherence to evidence
based guidelines for heart failure is overall poor amongst healthcare providers (Gohler et
al., 2006). Although the literature search yielded seven validated instruments for
screening for heart failure, none have been evaluated in an arrhythmia clinic setting.
In order to meet the project’s stated goals and objectives, a suitable and sound
research methodology was applied, and data collection approaches identified. Both,
methodology and study design, played instrumental roles in ensuring that the project met
its stated goals and objectives. The method or approach to data collection depends on the
type of data being collected, as well as the type of sources of data. For example, Hodges
and Videto (2011) argued that information gathered for the purposes of program
planning, should have both qualitative and quantitative components, and include primary
and secondary sources. The purpose of this chapter was to highlight the study

31
methodology, design, approaches to data collection, and strategies for analyzing the
collected evidence.
Practice-Focused Question
About 15% of this ADC patients are admitted or readmitted to hospital annually
due to exacerbation of heart failure, and/or ventricular arrhythmias. Despite these
statistics, previous practice in the ADC did not include the screening for signs and
symptoms of heart failure. As such, a simple, suitable, and reliable screening instrument
was needed in the ADC in order to facilitate a change this practice. In ambulatory,
outpatient arrhythmia devices clinic patient population, which of the three patient selfadministered heart failure symptoms questionnaires was the most suitable and feasible
screening tool to be implemented in this specialized setting?
Patient Population
Adult patients with a Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
or a Cardiac Resynchronization Therapy-Pacemaker (CRT-P), who presented to the
outpatient, ambulatory ADC located in a tertiary hospital in southwestern Ontario.
Issue
There was previously no screening being done or documented for heart failure
symptoms in patients attending the ADC. Existing screening questionnaires were
complex and time consuming.
Intervention
The main objective of the intervention was to compare the three questionnaires as
means of establishing suitability and fit of the screening tools in this specialized setting.
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Both the MLHFQ and the KCCQ have been previously validated as sensitive tools in
screening for heart failure symptoms, and the SHEFS questionnaire was a new tool
developed especially for the purposes of the clinic.
Comparison
No screening tools; previous practice.
Outcomes Measured
The primary outcome of this project measured the fit of the screening tool (or lack
of fit) for the clinical setting as well as the sensitivity of the tool in identifying heart
failure, as compared to the results of Brain Natriuretic Peptide (BNP) test—a specific
blood test performed to establish presence/absence of heart failure. Two secondary
outcomes have been subsequently identified one of which, was the evaluation of rates of
compliance of the staff in documenting the questionnaires’ results in the patient chart.
The final (secondary) outcome will look at evaluating the rates of readmission to the
hospital with symptoms of heart failure and/or ventricular arrhythmias requiring shock
from the device, after the screening tool has been implemented. Finally, a focus group
comprised of the instrument users was asked to evaluate the tools’ fit and suitability for
the practicum setting from their perspective, by using the Delphi technique.
According to Rowe and Wright (2011) the description of the Delphi
technique/method did not appear in print until 1975 although it has been developed by the
Rand Corporation sometime in the 1950s. Although initially slow in being adopted by the
wider audience, it has since gained popularity over the past couple of decades. It has been
used in several fields of study, and by various disciplines as a method of soliciting the
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opinions of experts to obtain an agreement or compromise on an issues or a topic. As Hsu
and Sandford (2007) argued, it is “well suited as a means and method for consensusbuilding” (p. 1). The traditional Delphi process involves four rounds of iterations (can
vary anywhere from three to five) and employs the use of questionnaires as means of
obtaining feedback. Each round of questionnaires asks the subjects to rate each item to
establish priority or importance. However, as Goodman (2017) argued, this approach can
sometimes create bias as subjects tend to rank/rate noncontroversial items higher than
those that are controversial.
Subject selection for the Delphi process is one of the most important aspects of
this method as the quality of results is highly dependent on the expertise of the
participants. In the case of this project, the three instruments were sent to the group of
end-users who were asked to rate the questionnaires using a survey monkey program.
Each individual in the group was asked to rate the questionnaires based on their
perception as to the usability and fit of the tool in the clinical setting as well as their
individual preference. Subsequently, the results were presented to the group at one of the
program’s weekly meeting. Consensus was determined by majority of the individuals
agreeing on one particular questionnaire as being the most suitable and preferable.
Time
The SHEFS questionnaire was administered in parallel to the MLFHQ, KCCQ,
and BNP testing for a period of one month. The second secondary outcomes will be
measured after six months of the best screening tool’s implementation.
Project Purpose and Method Alignment
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The purpose of this EB-QIP was to identify an effective screening tool for selfreported symptoms of heart failure in order to efficiently recognize those who are at an
increased risk of experiencing a cardiac arrest due to ventricular arrhythmia. By
comparing a newly developed tool to two already validated heart failure screening tools,
the project determined what tool was the most suitable for the arrhythmia clinic setting as
a screening instrument.
Key Operational Definitions
Characteristics of interest. Screening tool’s ability to identify and recognize
heart failure symptoms.
Measuring instrument. The measuring instruments were the three different selfreported heart failure symptoms questionnaires.
Method of test. Three questionnaires, assembled in a random order, were
administered to all consecutive patients meeting the pre-determined criteria.
Decision criteria. Each questionnaire’s score predicting a likelihood of heart
failure, as compared to the other two questionnaires and to BNP results (if done), was
deemed to be a sensitive tool for screening.
Statistical Package for the Social Sciences (SPSS), Version 19.0. A computer
statistical software used to perform statistical analysis of the outcomes data.
Univariate regression analysis. A statistical method used to explore for a
potential association between a single variable and a particular outcome of interest.
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Sources of Evidence
The possible sources of evidence were acquired from statistical data, evidencebased guidelines for heart failure and best nursing practice (CCS, HFSA, AHA, RNAO
guidelines), literature review, benchmarking to other like-organizations, existing hospital
policies/procedures, stakeholder input, national clinical guidelines review, program
specific databases, and evidence-based practice models. These sources of evidence
helped in identifying the magnitude of the practice problem as compared to other-like
organizations, the extent of use (or lack of use) of evidence based guidelines for heart
failure in the arrhythmia clinic setting, as well as any currently available screening tools
that have been previously validated.
Archival and Operational Data
This doctoral project involved in part, an analysis of the organization’s
operational data that is routinely collected as a component of its quality improvement
measurement. Specifically, the rates of admission and readmission to hospital with the
diagnosis of heart failure, amongst ADC patients, will be measured and compared
between pre-implementation, and six-month post-implementation of the recommended
screening tool.
The organization currently collects routine data on all hospital admissions
including the cause for admission, and diagnosis at discharge. The EP program data
analyst extracts the data that pertains specifically to the patients who are being followed
in the ADC. The analysis is subsequently presented to the senior administration members
of the program in database format.
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Description of Data Collection
The data for this project was collected through a retrospective review of the
patients’ health records with respect to the content and results of the questionnaires that
were completed as part of the patient’s recent visit to the ADC. This included a review
of the BNP blood results if they were completed.
Participants
The parties that contributed evidence to address the practice-focused question
were all those individuals who had completed the three questionnaires. As part of the
EB-QIP, all patients who had either a CRT-P, or CRT-D were identified prior to their
clinic visit, and subsequently asked to complete the questionnaires as part of their clinic
visit. A participation of total of 50-60 patients was initially planned in order to provide
meaningful data for analysis.
Procedures
For this project, two existing and validated tools (KCCQ-12 and MLHFQ) were
used to collect the evidence, along with a newly created tool (SHEFS questionnaire).
The KCCQ was initially developed by John Spertus and colleagues as a 23-item
questionnaire to quantify “physical limitations, symptoms, self-efficacy, social
interference and quality of life” in patient with congestive heart failure (Green et al,
2000, p. 1245). The tool has been subsequently validated in a number of different
conditions and settings (Joseph et al., 2013; Spertus et al., 2008; Tucker et al., 2016)
The KCCQ was subsequently reduced by Spertus and Jones (2015) to a 12-item
questionnaire (KCCQ-12) which demonstrated a preserved “validity, reliability,
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responsiveness, prognostic importance, and interpretability of the original instrument”
(Cardiovascular Outcomes Inc., 2016, p. 1). Spertus and Jones (2015) argued that the
shorter version of the original KCCQ was more feasible to be implemented without
compromising the psychometric properties of the original instrument. The KCCQ-12
measures the reported frequency of symptoms, physical and social limitations, and
alteration in quality of life because of heart failure. The score is calculated out of 70, and
the lower the score, the worse are the predicted outcomes including highest risk for
mortality and morbidity.
The MLHFQ was originally developed in 1984 at the University of Minnesota by
Thomas Rector, as a self-administered method of measuring the effects of heart failure
on an individual’s quality of life (Pietri et al., 2004). The tool has been since validated
through several research studies for validity and reliability in various settings, under
different conditions, and in different languages (Ahmeti et al., 2016; Bilbao et al., 2016;
Garin et al., 2009; Supino et al., 2009)
The questionnaire is composed of 21 questions, asking individuals to rate their
heart failure symptoms, functional limitations, and psychological responses, on a scale
from zero to five (zero representing no limitations, and five representing severe
limitations). The maximum possible score is 105, with the lower score representing little
or no effect on the individual’s quality of life, and higher score representing significant
limitations to quality of life.
The SHEFS questionnaire was initially developed by the DNP student in
conjunction with the medical director of the arrhythmia service. A draft of the

38
questionnaire was distributed to heart failure specialists in the organization for input and
comments (as experts in the field) prior to finalization. The final format of the
instrument is composed of five questions deemed by the heart failure experts to be the
minimum elements required in the assessment for symptoms of heart failure.
Analysis and Synthesis
The following paragraphs will outline this project’s approach with respect to
project design and collection methods. Description of the study patient population will
follow, containing details about inclusion and exclusion criteria. Finally, data collection
methods will be explained followed by description of the evaluation plan.
Data Systems and Procedures
The project followed a prospective cohort design (Sedgwick, 2013). This type of
design follows a group of similar individuals over a period of time. The patients with
CRT-P or CRT-D device were identified the day prior to their clinic appointment and
they were flagged for the study. The questionnaires were given to patients after they had
registered and while awaiting clinic appointment. The package of questionnaires
included a cover sheet (Appendix E) and the three questionnaires (SHEFS, KCCQ, and
MLHFQ). The order of the questionnaires in the package was assigned a randomization
sequence to prevent selection bias. The patients were asked to hand in their package to
the healthcare provider that physically checked their device. Copies of the questionnaires
were scanned into patient’s permanent electronic medical record, as per hospital policy
for all documents pertaining to patient’s visit. These records were then accessed to
review the completed questionnaires. The questionnaires were evaluated as to percentage
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of completion, measured heart failure prognostic score, and their ability to successfully
predict/identify heart failure as compared to the BNP results obtained during their clinic
visit. All data was entered into an Excel spreadsheet, and subsequently exported to an
SPSS (Version 19.0) program for analysis.
Population and Sampling
Inclusion criteria for the study was defined as adult patients (18 years or older)
who presented to the ADC of the hospital, who had either a CRT-D or a CRT-P device
in situ, and who were English speaking. Exclusion criteria was applied to patients who
were less than 18 years of age, to those who did not have a CRT-D or a CRT-P device,
who did not speak English, or those who refused to fill out the questionnaire.
Sampling method was defined as the inclusion of consecutive patients who met
the above criteria, over a period of one month.
Data Integrity
The patients were asked to fill out the questionnaires while waiting for their
appointment with the clinic staff. The questionnaires were then collected and results of
each tool entered onto patient’s ADC electronic record. Copies of the questionnaires
were then scanned (as per hospital’s protocol) to be included in permanent electronic
record. Prior to scanning into the hospital record, the questionnaires were reviewed to
ensure that they were correctly documented in the ADC’s electronic record.
Subsequently, the questionnaire data was retrieved at a later date to perform secondary
analysis. Any incomplete data was identified, recorded, and documented in the analysis.
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Data Analysis
The purpose of this quality improvement project was to assess for the most
suitable and appropriate screening tool to be used in this clinical setting, in order to
improve the management of heart failure in this patient population and subsequently, to
decrease the rates of readmission for heart failure and heart failure-related ventricular
arrhythmias. As such, the primary outcome for this study was the performance of the
three different questionnaires’ scores/results in their ability to predict or identify heart
failure as compared to the bedside blood test for brain natriuretic peptide (BNP). For this
project, both descriptive and inferential statistic were utilized to describe the basic
features of the data elements, and to analyze the relationship(s) (if any) between the
variables.
The purpose of descriptive statistics is to provide/present a summary of the
features of variables in the study, usually in the format of actual numbers (n), means,
percentages, and distribution across quartiles. In this study, descriptive statistics were
used to illustrate the quantitative characteristics of the data elements including age,
gender, type of device (CRT-D or CRT-P), method of EF measurement, degree of left
ventricular dysfunction, type of cardiomyopathy, previous history of heart failure,
evidence of admission to hospital for heart failure in the past six months, and most
responsible physician for heart failure care.
Inferential statistics were used to determine if there was a difference between
elements/groups, and if the observed difference was dependent rather than accidental.
For this study, the three questionnaires were compared to the results of the BNP blood
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test (as the gold standard) to determine a relationship (or lack of) between the
questionnaires and the BNP. Secondly, the SHEFS questionnaire was compared to the
MLHFQ and then to the KCCQ to determine if there was an association (a p-value of
<0.05 was considered to show statistical significance). Finally, univariate regression
analysis was performed to determine the association between the questionnaires’ scores,
including the BNP results, and other elements such as admission to hospital in the past
six months, NYHA functional class, medication class optimization, and ejection fraction.
The final secondary outcomes will look at rates of readmission to hospital with
symptoms of heart failure and/or ventricular arrhythmias requiring a shock from the
device, after the recommended screening tool has been implemented.
Project Evaluation Plan
The evaluation plan had fourfold objective: to analyze and determine the
sensitivity (or lack of) of the newly development SHEFS questionnaire in identifying
heart failure as compared to the KCCQ, the MLHFQ, and the BNP, to determine which
questionnaire was most suited for the ADC patient population given the current
resources and environment, to determine the rates of compliance by staff in documenting
results of the questionnaires, and to determine if rates of readmission to hospital with
heart failure among this clinic’s patients has improved six months after implementing
the recommended screening tool.
Summary
In this section of the paper, the project question was outlined and stated in terms
of patient population, intervention, control, observation, and time line. Subsequently, the
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study design and methods were explained with respect to the method of data collection,
type of participants, and mode of implementation procedures. Subsequently, the
organization’s archival and operational data was identified as the main source of
information required for project evaluation. In the following section, project findings and
resultant recommendations will be presented and discussed.
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Section 4: Findings and Recommendations
Introduction
Despite the best available treatments, heart failure remains a major cause of
morbidity and mortality worldwide. Half of the individuals diagnosed with heart failure
will die within five years of the initial diagnosis, and one quarter will die within one year
(Gerber et al., 2015). In 2012, the global economic burden of the direct and indirect costs
associated with heart failure care were estimated at $108 billion for that year, and these
costs will likely continue to rise as the population ages (Cook et al., 2014).
Advanced or ongoing heart failure leads to a progressive left ventricular
remodeling which subsequently contributes to abnormalities in the cardiac structure and
function, resulting in the development of ventricular arrhythmias requiring treatment from
an ICD. Despite the direct link between heart failure and ventricular arrhythmias, the
ADC did not previously screen patients for symptoms of the disease.
A recent review of the EP program database showed that close to 15% of the ADC
patients are admitted and readmitted to hospital on annual basis with the diagnosis of
heart failure and/or ventricular arrhythmias. As a result of this data, the program’s
executive team identified heart failure care as the priority for their program quality
improvement initiative.
Evaluation of existing practice identified that ADC nurses did not assess patients
for heart failure. Given that heart failure and arrhythmia are inter-related, this poor
approach to patient care acknowledged a significant gap in practice. As such, screening
for heart failure symptoms within the ADC was identified as an area in need of
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improvement. As a result, a quality improvement project was developed and designed to
identify and determine the most appropriate, suitable, and feasible screening tool for heart
failure in the ADC setting. The core of the practice-focused question was which selfadministered heart failure screening tool was most suitable in this specialty setting.
Subsequently, two previously validated tools and one newly developed tool were
administered to a select patient population within the ADC to evaluate their effectiveness
in predicting heart failure. The purpose of this doctoral project was to evaluate all three
tools and recommend the one that would be most appropriate in this clinical setting.
Evidence for this project was obtained from the results of three self-administered
questionnaires that were given to patients as part of their visit to the ADC. The
questionnaires were initially administered as part of a quality improvement project to
promote heart failure screening within the ADC. Subsequently, the information obtained
from each of these questionnaires was accessed for analysis as to their predictive
characteristics and feasibility of use in the ADC. An approval from the site’s Research
Ethics Board (REB) (Appendix H) as well as the Walden University’s Institutional
Review Board (IRB) (Appendix G) was obtained prior to implementation of the project.
Findings and Implications
Demographics and Descriptive Data
Over a period of one month, a total of 76 patients were identified for the study.
Out of the total, 14 patients were identified as missed opportunity as they did not receive
the package of questionnaires at the time of the clinic registration and therefore, were not
included in the study. Out of the remaining 62 patients who did receive the package of
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questionnaires, two did not speak English and therefore were unable to complete the
questionnaires resulting in the two questionnaire packages being excluded from analysis.
Subsequently, 60 questionnaire packages were analyzed. Questionnaire packages that
were incomplete (either one or more of the questionnaires in the package was not
completed) were also excluded, resulting in 55 patients being included in the final study
analysis.
Of the 55 patients, 14 (25%) were female, and 41 (75%) were male. The average
age of study patient was 69 years with a range between 41 and 85 years of age. Fortythree (78%) of the 55 patients had previously documented history of heart failure, and 12
(22%) did not. Approximately 10% of patients (n = 5) have had documented history of
admission to hospital with heart failure in the past six months.
Distribution of patients with respect to device type, type of cardiomyopathy, New
York Heart Association (NYHA) functional class, the degree of left ventricular (LV)
dysfunction, and method of ejection fraction (EF) measurement is represented in Table 1
(Distribution of patients), and the degree of LV function is represented in Table 2 (Left
ventricular function).
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Table 1
Distribution of patients
Variable
Device type
CRT-P
CRT-D
Type of cardiomyopathy
Ischemic
Non-ischemic
NYHA class
I
II
III
IV
Not documented
Degree of LV dysfunction
Normal
Mild
Moderate
Severe
Not documented
Method of EF measurement
Echo
RNA
Angiogram
Not documented

n

%

9
46

16.4
83.6

25
30

45.5
54.5

3
21
19
0
12

5.5
38.2
34.5
0
21.8

1
10
7
34
3

1.8
18.2
12.7
61.8
5.5

38
8
4
5

69.0
14.6
7.3
9.1

Table 2
Left ventricular function
Ejection fraction %
Normal
Mild dysfunction
Moderate dysfunction
Severe dysfunction

50% and >
40-50%
30-49%
<30%
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The study patients reported that the most responsible physicians (MRPs) for their
heart failure care were as follows: general practitioner (n = 6, 11%), cardiologist (n = 47,
75%), internist (n = 1, 2%), and heart function clinic specialist (n = 1, 2%).
With respect to heart failure medications, the CCS (2015) recommends that three
main classes of medications be prescribed for patients with the disease: angiotensinconverting enzyme inhibitors (ACEIs), beta blockers (BBs), and mineralocorticoid
receptor antagonists (MRAs). Out of the 55 study patients, 45 (82%) were on some type
of ACEI, 50 (91%) were on a BB, and only 24 (44%) were on MRA. Only 20 (36%) were
on all three recommended medications, and merely one individual was on optimal doses
of all three classes of recommended medications.
Results for the Heart Failure Screening Tools
Because heart failure is a collection of signs and symptoms, none of the
questionnaires could confidently predict heart failure based on one measurement alone.
As such, the diagnosis of heart failure could only be stated as “likely” or “unlikely.”
The average KCCQ score was 51.1, ranging from 27 to 67, with a score of 35 of
less corresponding to “likely” heart failure (Green et al., 2008). Eight patients (14.5%)
met the criteria of “likely” having heart failure i.e. scoring 35 or less on the questionnaire.
The average MLHFQ score was 24.5 with a range of 0 to 68, with a score of 53 or
greater corresponding to patients “likely” having heart failure (Rector et al., 1987). Seven
patients (13%) met the criteria of “likely” having heart failure (i.e. scoring 53 or greater
on the questionnaire).
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The average SHEFS questionnaire score was 0.5, ranging from 0 to 5, with a score
of 1 or greater corresponding to “likely” heart failure. Therefore, as per this criterion, 18
patients (32.7%) “likely” had heart failure.
The average NT-proBNP (BNP) result was 1216, with a range between 62-3556
pg/ml. Approximately 30% of the study patients (n = 15) had BNP test completed. Out of
these patients, 6 (40%) “likely” had heart failure. Confirmation of heart failure was based
on the BNP reference range presented in Table 3 (Mangla, 2014).
Table 3
Brain-type natriuretic peptide (BNP) reference range
Heart failure unlikely
<300 pg/ml

Heart failure likely
age <50 years, NT-proBNP >450 pg/ml
age 50-75 years, NT-proBNP >900 pg/ml
age >75 years, NT-proBNP >1800 pg/ml

In the 15 study patients who had NT-proBNP blood test completed, 13 (87%) of
the results (heart failure likely or heart failure unlikely) corresponded to the SHEFS
results, as compared to 11 (73%) corresponding to the MLHFQ results, and 11 (73%)
corresponding to the KCCQ results. Of the 15 study patients who had all of the four test
results available (NT-proBNP, SHEFS questionnaire, MLHFQ, and KCCQ) 10 (67%)
were all in agreement with respect to heart failure being “likely” or being “unlikely.”
Comparison within the group of three (SHEFS questionnaire, MLHFQ, and
KCCQ) showed that SHEFS matched the MLHFQ results 72% (n = 40) of the time, and
the KCCQ 75% (n = 41) of the time. MLHFQ results matched the KCCQ results 87% (n
= 48) of the time. Comparison within the four groups is presented in Appendix J.
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All three questionnaires identified symptoms of heart failure. However, both the
KCCQ and the MLHFQ took considerably longer to complete as they were composed of
12 and 21 questions respectively, as compared to SHEFS questionnaire, which had only
five questions. Secondly, both the KCCQ and the MLHFQ had a larger scale (1-7 and 0-5
respectively) of rating which could result in under or over reporting of symptom severity.
SHEFS questionnaire on the other hand, required only YES/NO answers and the
questions were easy to understand.
With regards to the domains measured, both the KCCQ and the MLHFQ
measured elements in the physical and emotional domains whereas the SHEFS
questionnaire focused entirely on measuring physical symptoms.
Finally, the SHEFS questionnaire had the higher rates of agreement with the NTproBNP results for presence or absence of heart failure than either the KCCQ or the
MLHFQ. When comparing the SHEFS questionnaire, the MLHFQ, and the KCCQ to the
NT-proBNP results, SHEFS had the highest percentage of sensitivity and it was as
specific as the KCCQ but less specific than the MLHFQ. When comparing the SHEFS
questionnaire to both the MLHFQ, and the KCCQ individually, the SHEFS had similar
percentage of sensitivity and specificity for both groups.
Documentation and Follow up Results
With respect to the health care providers (HCP) reviewing questionnaires with the
patient, only 40 (73%) commented that they reviewed the results. Two of the 40
questionnaires reviewed by the HCPs resulted in a referral to a heart function clinic, four
in a referral to the Nurse Practitioner (NP), six in a referral to the MRP, and 27 in no
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action taken. None of the patient charts showed evidence of documentation that the
questionnaires were completed or reviewed, what the results of the questionnaires were,
or what was the follow up of positive results.
Unanticipated Limitations or Outcomes and Their Potential Impact on the Findings
One of the major limitations of the project that may have a potential impact on the
findings was the fact that only 15 (27%) patients had NT-proBNP blood tests done. This
test is very expensive to perform and only a select group of patients have it completed.
The decision to have the NT-proBNP done or not is made by the MRP at the time of
patient encounter, and it is based on a number of factors such as the patient’s condition at
the time, patient’s past health history, presence of other comorbid diseases that may mask
heart failure, and/or the MRP’s clinical judgment.
Another unanticipated limitation that may have a potential impact on the findings
was the fact that both the organization and the ADC are currently undergoing many
operational and system changes including changes in staffing complements and staffing
models. The arrhythmia program’s previous all registered nurse (RN) model has shifted
recently to a majority cardiovascular technologist (CVT) model. The two roles have
different job descriptions, different scopes of practice, different practice standards, and
different level of knowledge. Hence, the emphasis on physical assessment may be lower
among the CVTs. Secondly, their level of understanding of the implications of positive
screening findings may differ significantly. This may contribute to under reporting of
patient symptoms and subsequently, to under- identify of these patients for further follow
up.
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Ethical, Legal, and Economic Implications
Within the ethical context, screening of all appropriate patients for heart failure
ensures that patients are receiving fair, equal, and equitable care and services, which falls
within the ethical principal of justice. Self-reporting of symptoms also allows for a degree
of autonomy and self-determination whereas patients may choose to under or over report
their symptoms or choose not to fill out the questionnaire at all. Implementing the heart
failure screening tool within the ADC setting is also beneficent and non-maleficent, as
there is a clear benefit of screening all appropriate patients for heart failure, and it does
not cause harm.
From legal perspective, the questionnaire is not mandatory and therefore patients
are not legally obligated to complete it. However, if and when patients complete the
questionnaire/screening tool, it becomes a legal part of their medical record which is
protected by privacy laws. Therefore, there are minimal legal implications for this project.
Within the economic context, implementing a heart failure screening tool will
result in better heart failure management in the ADC. Early symptom identification may
delay or completely avoid an admission to hospital with heart failure, resulting in
substantial direct and indirect cost savings. Implementation of the tool itself, will require
minimal resources as it is self-administered.
Implications in Terms of Individuals, Communities, Institutions, and Systems
The implications resulting from the project findings have multi-level effects. In
terms of individuals, the findings showed that close to half of the ADC patient population
was experiencing one or more symptoms of heart failure at the time of their clinic visit.
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Without a screening tool, these patients would be potentially not identified and/or missed
to follow up. This could subsequently result in these patients requiring an unplanned
admission to hospital with heart failure, or in these patients experiencing a decreased
quality of life because of their symptoms.
From the community perspective, the ADC provides expert care to all patients
living within its local integrated health network—a geographically defined regional area.
As such, it has the obligation to ensure that it is providing the best care to all of its
members within the region. The best care includes a comprehensive management of heart
failure in those who have a history of the disease, as well as those who are at risk for
developing the disease.
From institution point of view, the implication of not implementing any screening
tool at all creates the risk that the current practice will continue to maintain poor
standards of care, and fail to meet professional practice standards. This approach will also
contribute to underutilization of best evidence, research, and expert knowledge.
Documentation of findings and follow up on positive screening results is crucial
to the success of the project (i.e. why screen if nothing is going to be done about the
results?). In fact, the next step of this project is to develop a policy and procedure on how
to deal with positive findings.
Finally, from the systems perspective, the implication resulting from the project
findings is that it will require an involvement and a coordinated effort between all
members of the ADC staff to make this change a success. For example, the business
clerks must supply all ADC patients with the questionnaire at the time of registration, the
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CVTs and RNs must review and document the results of the screening tool as well as
refer for appropriate follow up, and the NP and/or the MRP must ensure that an
appropriate heart failure management is initiated. Finally, the manager of the clinic as
well as the program director must support and enforce these activities, and the educator
must be available as a resource for heart failure education.
Implication to Positive Social Change
Within the social context, the project findings have the potential of bringing about
a positive social change not only within the culture of the clinic itself, but also within the
organization, and overall in the nursing profession. By changing behaviors, attitudes,
values, patterns, and norms, the project findings will likely challenge, drive, modify and
adjust current structures and arrangements.
From the ADC staff perspective, the findings will conceivably result in a change
of the individual member’s values, beliefs, and opinions with respect to the significance
and importance of screening for heart failure. The recommended interventions will also
potentially change the staff members’ previous habits, behaviors, and practice routines.
This in turn will both, generate and facilitate better patient care and, improve health
outcomes.
From the organizational and systems perspective, the project findings will likely
force a change in the existing policies and procedures with respect to management of
heart failure in the ADC. By establishing and applying practice standards that meet the
requirements of the profession, and ensuring that the latest research is incorporated in the
organization’s policies and procedures, will lead to positive social change.
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Finally, from the nursing profession perspective, the project findings will lead to
improved patient care by nurses in other like-settings. For example, by effectively and
efficiently identifying those who are at risk, the screening tool can be implemented by
other nurses in family practice settings, in cardiology outpatient offices, or in any other
outpatient clinics.
Recommendations
The SHEFS questionnaire met the basic requirements for screening for heart
failure in the ADC population: quick to complete, easy to understand and answer, able to
identify the main physical symptoms of heart failure, and shown to be more predictive of
heart failure in this setting as compared to the previously validated heart failure screening
tools (KCCQ and MLHFQ). Secondly, when compared to the other two heart failure
screening tools, the SHEFS questionnaire was determined by the end users to be a more
suitable screening tool for this patient population. As such, the first recommendation is to
implement the SHEFS questionnaire as the tool of choice for heart failure screening in the
ADC.
The second recommendation is to ensure that heart failure screening is a
mandatory and standard element of patient’s medical record completed by the staff during
a patient visit to the ADC. This approach will ensure that all patients, regardless of the
type of device or risk factors, are appropriately assessed, identified, and referred for
further appropriate heart failure care. Development of organizational policy and
procedure for this new practice would be highly recommended to prevent missed
opportunities and avoided complications of heart failure and/or admission to hospital.
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The third recommendation is to mandate that an appropriate education on heart
failure be completed by each of the staff as part of their orientation to the clinic. Being
able to recognize not only the importance of screening for heart failure in this particular
patient population, but also the most common signs and symptoms, would assist the
HCPs in identifying those who are at risk and subsequently, intervening and/or
implementing appropriate therapies.
The fourth recommendation is to implement an appropriate and concrete
documentation tool that would promote and encourage heart failure screening in the
ADC. Currently, the rudimentary, and very basic, documentation process is not user
friendly, includes only the health care provider’s subjective interpretation of patient’s
condition, and does not address the essential components of physical assessment.
The fifth recommendation is to develop policy and procedure with respect to
follow up of positive heart failure screening tool findings. Because of the multitude of
different providers involved in patient’s care, it is often difficult to ascertain who is most
responsible or most appropriate to address the heart failure symptoms. A proposed
decision tree for HCPs who find positive results on the screening tool is included in
Appendix K.
Strengths and Limitations of the Project
One of the limitation of the project was that it included only patients who had a
CRT-D or CRT-P device, as they have a known and documented history of heart failure
(an initial indication for the implantable cardiac device). However, there may be other
patients with an implantable cardiac device such as Permanent Pace Maker (PPM) or
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Implantable Cardioverter Defibrillator (ICD) who may exhibit initial or ongoing signs
and symptoms of heart failure and who have not been included in the screening.
Another limitation of the project was the fact that the HCPs were not ready for
this practice change, as evidenced by the lack of documentation of the questionnaires, or
its outcomes, in the patient’s clinic chart by the HCPs. As McEntee, Cuomo, and
Dennison (2009) contended, barriers to adherence to guidelines at the provider level are
often related to practice environment constraints, time limitations, attitudes and beliefs
of those involved, as well as the provider’s level of knowledge of guidelines, and his/her
comfort with recommended treatment.
One of the strengths of this project was that the tools contributed to an additional
knowledge of the patient’s status/condition. For example, the provider’s review of the
patient’s self-reported symptoms, may have provided the opportunity in offering
additional information that may perhaps not be normally elicited during a typical patient
encounter. This information could have altered the course of treatment or therapy.
Secondly, this type of screening can be applied in instances/settings where time
resources are limited, and therefore self-report of symptoms can avert addition of extra
resources required to collect the information. This type of screening tool therefore, is
versatile and universal, and subsequently, can be applied in other like-settings.
Finally, the strength of the project is the fact that it specifically addresses nursing
practice and contributes to further professional knowledge. As such, nurses in other
specialties can apply this project’s findings in their own areas of practice or draw on the
finding to implement their own projects.
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Recommendations for Future Projects
One of the main recommendations for similar future projects is to actively
involve the clinic staff in the development and evaluation of the project through small
steps approach in order to maintain the momentum, and to retain their interest and
enthusiasm.
Secondly, the value and the significance of having the relevant and applicable
background education on the disease being assessed (heart failure), cannot be
underestimated. Without the basic knowledge of the pathophysiology of the disease, its
prevalence, incidence, prevailing signs and symptoms, it may be difficult for the
HPCs/stakeholders to understand why screening is important.
Thirdly, it is important to ensure that the time elapsed between project design and
implementation is short. As mentioned above, some of the staff’s interest in the project
declined over time, and it was difficult to re-engage them.
Fourthly, it is crucial that the researcher is familiar and comfortable with the
different research methodologies and approaches, even prior to determination of study
goals and objectives. Knowing what to look for (outcomes), and how to look for it
(methods) can make a significant difference. This knowledge plays an especially
important role in the interpretation of findings.
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Section 5: Dissemination Plan
Dissemination Plan
As Forsyth et al. (2010) contended, it is crucial that all new knowledge gained
through evidence-based projects be disseminated. According to Hampton et al. (2011)
presenting program results/outcomes in a public forum allows for exposure of the issue to
the greater audience which can help in raising awareness and drawing in and mobilizing
additional support. Bringing attention to the issue at hand may not only help in obtaining
added financial and human resources, but also in generating and guiding future policies.
Institution Experiencing the Problem in Practice
In order to disseminate the results of this work to the organization in which this
project was completed, a number of different approaches and methods will be utilized.
First of all, an executive summary of the project and project findings delivered to
the senior management of the program, will identify the clinical issue/problem in question
(as supported by organizational data), describe the methods of addressing this problem
(project), present the outcomes/results, and list the suggested recommendations. The
focus of this summary will be to identify strategies that will bring the changes forward,
and to generate the necessary support needed for these strategies. Secondly, the purpose
of this program level presentation will be to inform the administration of the current
status of the program and the changes needed for improvement.
A power point presentation will be subsequently delivered to all of the
stakeholders (including the arrhythmia clinic staff) at an arrhythmia grand rounds, and/or
at cardiology grand rounds held on weekly basis in the organization. Through this venue,
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the project results can inform others within the organization of the quality improvement
work that is being done within the program.
Broader Nursing Profession
With respect to the broader nursing profession, the results of the program will be
presented in the format of scientific poster at local, provincial, and/or national nursing
conferences. Sharing the results of the project as well as the challenges and successes,
may help other nurses in implementing similar projects within their own clinical settings.
One of the conferences in particular that may be most appropriate for this project’s result
dissemination is the annual Canadian Cardiovascular Society Congress meeting which
includes the Canadian Council of Cardiovascular Nurses (CCCN) chapter. This particular
national association’s vision aligns with my own professional and personal goals: to
advance “cardiovascular nursing through leadership, advocacy, research and knowledge
translation” (CCCN, 2017).
Finally, submission of a manuscript to a peer-reviewed national or international
nursing journal will help in disseminating the knowledge and ideas to a broader audience.
A good quality professional journal with an international recognition and reputation, will
ensure that the results are read by other nurses with a keen interest in advancing the
nursing profession.
Analysis of Self
As a Scholar
By completing the DNP program, I will achieve the terminal degree for my
profession. However, now more than ever I realize that the learning will never end, nor
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should it end. The journey of discovery will continue in my daily practice and I hope to
instill this enthusiasm for learning to the nursing students I mentor, and to the nurses I
work with. By providing leadership and role modeling to other nurses and nursing
students through completion of this advance degree, will put me in a position where I can
support them and offer advice.
Completing the DNP program will also signal the realization of my life long goal.
It will symbolize the accomplishment of a very arduous, but rewarding personal journey
to fulfill a personal challenge I set out for myself. It will also give me the opportunity to
prove to myself, my colleagues, my family, and my friends that I could do this.
As the move towards DNP degree as the entry into advanced practice approaches,
it is also imperative that as a practicing nurse practitioner, I am prepared and hold the
necessary qualifications.
Thirdly, completion of the DNP program will provide me with the necessary
skills, knowledge, and competencies to contribute to the exploration of nursing practice
issues and subsequently, to translation of applicable and relevant research findings to
address these issues in order to advance nursing both as a profession, and as a science.
As a Practitioner
According to one of the American Association of Colleges of Nursing’s (2006),
essentials of Doctoral Education for Advanced Nursing Practice (essential II) the DNP
program prepares its students to employ the “principles of business, finance, economics,
and health policy to develop and implement effective plans for practice-level and/or
system-wide practice initiatives that will improve the quality of care delivery” (p. 11).
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Development, implementation, and evaluation of the DNP project has definitively
prepared me to lead future projects and actively participate in continuous quality
improvement within the organization, the program, and my profession. The DNP
experience has given me the confidence, the knowledge and the skills as a practitioner, to
develop further projects that will influence and affect not only individuals, groups,
communities, and populations, but also the nursing profession.
As a practitioner, I will be better equipped to promote and model the use of
evidence at patient, provider, and system levels. I will have the background to actively
contribute to positive changes in the clinical practice.
As a Project Developer
The most difficult role to play in this project was that of the project developer. It
was very challenging to initially get the buy-in from the nursing staff, and I constantly
struggled with ensuring that the project was implemented accordingly. Numerous email
reminders as well as individual meetings were necessary for the project to be completed.
On a more positive note, as a project manager I had the opportunity to apply
gained knowledge and skills to design, implement, and evaluate a clinical program within
the organization on my own. The prospect of leading the entire project, rather than being
a passive participant, was initially quite daunting. However, given that the project was
going to influence outcomes and contribute to best care, the experience was very
rewarding. Finally, by recommending innovative approaches to improving patient care, in
view of the resource constraints, I felt that I was really making a difference.
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Challenges, Solutions, and Insights
Overall, my experience of completing this DNP project has been a very positive
one. There has been no major glitches, interruptions, or setback. It has been a very
challenging but also a rewarding experience that required a tremendous physical and
emotional commitment. However, to see the project progress from mere notions and ideas
to a finished product, was both exciting and gratifying.
One of the biggest challenges of completing my DNP project was the time interval
that was required to complete the different stages of the project, starting with the
proposal, through the IRB process, and finally implementation and evaluation. However,
each stage of the project was a crucial component that needed to be completed in order to
naturally proceed to the next stage. Nevertheless, this time lag played a key role when the
time for implementation came about. Having heard about the project months ago, the
clinic staff forgot about the project details, and also lost some of their enthusiasm when
the time came to implement. To address this challenge in future projects, it would be
worthwhile to bring all of the stakeholder together again before implementation, in order
to generate a renewed interest and enthusiasm about the project.
What I learned most about this scholarly journey, is that it takes a lot of time and
planning to get things rights. In my previous experience, projects that were rushed
through, or ones that took shortcuts, failed either before implementation, or before
evaluation was completed. As such, a well-designed project/study requires the ongoing
commitment from the project leader, and continuous attention to details.
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Summary
Heart failure continues to pose a significant burden on the society due to its
resource-intensive requirements and resultant financial costs. As such, the need to quickly
and effectively identify those who have heart failure or who are at risk for heart failure, is
of the highest priority, regardless of the clinical setting. Screening tools which employ
patient administered self-reported symptoms of heart failure questionnaires, allow for an
efficient and effective method of identifying those at highest risk. This is especially true
in an ADC setting where resources are limited, and the mandate does not incorporate full
physical assessment and focused history taking into clinic visit. This doctoral project
allowed for the examination, evaluation, and recommendation of the most appropriate and
suitable screening tool for the ADC.
After a comprehensive and detailed analysis of the project data, the project leader
concluded that the best heart failure screening tool for the ADC setting was the SHEFS
questionnaire. It was the simplest tool to complete with the least amount of resources
required. The tool also performed better with respect to identifying those who are more
likely to have heart failure, when compared to the other heart screening tools such as the
KCCQ and the MLHFQ, based on the concordance to the gold standard test for heart
failure: the NT-proBNP blood test. As a result of these findings, a number of
recommendations were made.
First of all, the project leader recommended that the SHEFS questionnaire be
implemented as the screening tool of choice for the ADC. Secondly, that the screening for
heart failure in the ADC become an expected standard. Thirdly, that a mandatory
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education on heart failure be provided to all new staff members to the ADC. Fourthly,
that a comprehensive documentation tool be implemented in place of the existing tool.
Finally, that a policy and procedure be developed with respect to follow up care of
patients with positive heart failure screening results.
The purpose of this doctoral project was to translate the knowledge, skill, and
experience acquired through the process of designing, implementing, and evaluating a
quality improvement project, in order to guide and direct nursing practice changes
reflective of latest research and evidence. Ultimately, the project outcomes resulted in
recommendations for the practice setting, as well as organizational system changes, in
order to improve the quality of healthcare delivery whilst meeting the needs of the
individuals and the community in question.
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Appendix A: Heart Failure Screening Tools
Tool/Instrument
Name
KCCQ

Description

Reference

-Domains assessed: physical
Green et al., 2008
limitations, symptoms, self-efficacy,
social limitations, quality of life
-23 item questionnaire
-Scoring ranges from one to seven
(one representing severe limitations
or high frequency of symptoms, and
seven representing no limitations or
rare occurrence of symptoms)
-Maximum possible score is 150,
with lower scores representing
significant effect on quality of life,
and higher score representing little or
no effect on quality of life

KCCQ-12

-12 item questionnaire
-scoring as per KCCQ
-Maximum possible score is 70 with
lower scores representing significant
effect on quality of life, and higher
score representing little or no effect
on quality of life

MLHFQ

-Domains assessed: physical,
emotional
-21 item questionnaire
-Scoring scale ranging from zero to
five (zero representing no limitations
to activities and five representing
limitations at all times)
-Maximum possible score 105, with
lower scores representing no effect
on quality of life, and higher scores
representing significant effect

Chronic Heart
Failure
Questionnaire

-Domains assessed: dyspnea, fatigue, Guyatt et al., 1989
emotional
-16 item questionnaire
-scoring from worst to best with
scores ranging between 16 and 112

Rector et al., 1987
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Quality of Life
Questionnaire in
Severe Heart
Failure

Left Ventricular
Dysfunction
(LVD-36)

Cardiac Health
Profile Congestive
Heart Failure

Chronic Heart
Failure
Assessment Tool

-measures longitudinal change over
time
-Domains assessed: psychological,
physical activity, life-dissatisfaction,
somatic symptoms
-26 item questionnaire
-scoring from best to worst with
scores ranging between 0 and 130
-self-assessment of health related
quality of life in severe heart failure
-Domains assessed: not clear
-36 item questionnaire
-scoring from best to worst with
scores ranging between 0 and 100
-measures the impact of LVD on
quality of daily life and overall wellbeing
-Domains assessed: not clear
-10 item visual analog scales to
determine patient’s perception of
how heart failure influences
physical, psychological, and social
well-being
-Domains assessed: symptoms,
activity levels, psycho-social,
emotions
-46 items measured through a variety
of scales to assess patient’s
perspective of quality of life in heart
failure

Wiklund et al., 1987

O’Leary et al., 2000

Mannheimer et al., 2007

Dunderdale et al., 2008
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Appendix B: Self-Reported Heart Failure Symptoms (SHEFS) Questionnaire

Arrhythmia Devices Clinic Questionnaire
Please take a few minutes to let us know how you have been feeling since we last saw you in
our clinic:
YES

NO

DON’T
KNOW

Since we last saw you, have you been more short of breath than usual?
Since we last saw you, have you had to sleep on more pillows than
usual to help with your breathing?
Since we last saw you, have you been awakening at night feeling short
of breath?
Since we last saw you, have your feet or abdomen been more swollen?
Since we last saw you, did you require adjustment of your water pill?
Is there anything you would like to ask about your device today?
Please specify:________________________________________________
Who looks after your heart failure, or adjusts your water pill? (please circle)
Cardiologist

Family Doctor

Heart Function Clinic

Don’t know
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Appendix C: Minnesota Living with Heart Failure Questionnaire (MLHFQ)
MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE
The following questions ask how much your heart failure (heart condition) affected your
life during the past month (4 weeks). After each question, circle the 0, 1, 2, 3, 4 or 5 to
show how much your life was affected. If a question does not apply to you, circle the 0
after that question.
Did your heart failure prevent
you from living as you wanted during
the past month (4 weeks) by -

No

Very
Little

Very
Much

1. causing swelling in your ankles or legs?
0
1
2
3
4
5
2. making you sit or lie down to rest during
the day?
0
1
2
3
4
5
3. making your walking about or climbing
stairs difficult?
0
1
2
3
4
5
4. making your working around the house
or yard difficult?
0
1
2
3
4
5
5. making your going places away from
home difficult?
0
1
2
3
4
5
6. making your sleeping well at night
difficult?
0
1
2
3
4
5
7. making your relating to or doing things
with your friends or family difficult?
0
1
2
3
4
5
8. making your working to earn a living
difficult?
0
1
2
3
4
5
9. making your recreational pastimes, sports
or hobbies difficult?
0
1
2
3
4
5
10. making your sexual activities difficult?
0
1
2
3
4
5
11. making you eat less of the foods you
like?
0
1
2
3
4
5
12. making you short of breath?
0
1
2
3
4
5
13. making you tired, fatigued, or low on
energy?
0
1
2
3
4
5
14. making you stay in a hospital?
0
1
2
3
4
5
15. costing you money for medical care?
0
1
2
3
4
5
16. giving you side effects from treatments?
0
1
2
3
4
5
17. making you feel you are a burden to your
family or friends?
0
1
2
3
4
5
18. making you feel a loss of self-control
in your life?
0
1
2
3
4
5
19. making you worry?
0
1
2
3
4
5
20. making it difficult for you to concentrate
or remember things?
0
1
2
3
4
5
21. making you feel depressed?
0
1
2
3
4
5
_________________________________________________________________________
©1986 Regents of the University of Minnesota, All rights reserved. Do not copy or reproduce without permission.
LIVING WITH HEART FAILURE® is a registered trademark of the Regents of the University of Minnesota.
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Appendix D: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
The following questions refer to your heart failure and how it may affect your life. Please read and complete the following
questions. There are no right or wrong answers. Please mark the answer that best applies to you.
1. Heart failure affects different people in different ways. Some feel shortness of breath while others feel fatigue. Please
indicate how much you are limited by heart failure (shortness of breath or fatigue) in your ability to do the following
activities over the past 2 weeks.
Limited for
other reasons
Extremely
Quite a bit
Moderately
Slightly
Not at all
or did not do
Activity
Limited
Limited
Limited
Limited
Limited
the activity
a. Showering/bathing

O

O

O

O

O

O

b. Walking 1 block on
level ground

O

O

O

O

O

O

c. Hurrying or jogging
(as if to catch a bus)

O

O

O

O

O

O

1

2

3

4

5

6

2. Over the past 2 weeks, how many times did you have swelling in your feet, ankles or legs when you woke up in the
morning?
3 or more times
per week but
Less than
Never over the
Every morning
not every day
1-2 times per week
once a week
past 2 weeks

O

O

O

O

O

1

2

3

4

5

3. Over the past 2 weeks, on average, how many times has fatigue limited your ability to do what you wanted?
All of
the time

Several times
per day

At least
once a day

3 or more times
per week but
not every day

1-2 times
per week

Less than
once a week

Never over the
past 2 weeks

O

O

O

O

O

O

O

1

2

3

4

5

6

7

4. Over the past 2 weeks, on average, how many times has shortness of breath limited your ability to do what you
wanted?
3 or more times
All of
Several times
At least
per week but
1-2 times
Less than
Never over the
the time
per day
once a day
not every day
per week
once a week
past 2 weeks

O

O

O

O

O

O

O

1

2

3

4

5

6

7

5. Over the past 2 weeks, on average, how many times have you been forced to sleep sitting up in a chair or with at
least 3 pillows to prop you up because of shortness of breath?

Every night

3 or more times
per week but
not every day

1-2 times
per week

Less than
once a week

Never over the
past 2 weeks

O

O

O

O

O

1

2

3

4

5
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KCCQ-12
Page 2 of 2
6. Over the past 2 weeks, how much has your heart failure limited your enjoyment of life?
It has extremely
limited my enjoyment
of life

It has limited my
enjoyment of life
quite a bit

It has moderately
limited my enjoyment
of life

It has slightly
limited my enjoyment
of life

It has not limited
my enjoyment
of life at all

O

O

O

O

O

1

2

3

4

5

7. If you had to spend the rest of your life with your heart failure the way it is right now, how would you feel about this?
Not at all
satisfied

Mostly
dissatisfied

Somewhat
satisfied

Mostly
satisfied

Completely
satisfied

O

O

O

O

O

1

2

3

4

5

8. How much does your heart failure affect your lifestyle? Please indicate how your heart failure may have limited your
participation in the following activities over the past 2 weeks.
Severely
Limited

Limited
quite a bit

Moderately
limited

Slightly
limited

Did not
limit at all

Does not apply
or did not do for
other reasons

a. Hobbies, recreational
activities

O

O

O

O

O

O

b. Working or doing
household chores

O

O

O

O

O

O

c. Visiting family or
friends out of your
home

O

O

O

O

O

O

1

2

3

4

5

6

Activity

Rev. 2012-04-16
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Appendix E: Cover Letter for Patients

Arrhythmia Devices Clinic
Dear patient:
We are continuously finding new ways to improve the
quality of care we provide to our patients, such as you.
As part of this quality improvement process, we would
like to ask you to complete the attached questionnaires
while you are waiting for your appointment with our
clinic staff.
The purpose of these questionnaires is to help us
identify any changes in your health as it relates to your
visit today.
There are three questionnaires. Once you complete
them, please give the package to one of the health care
providers you see during your appointment.
Thank you,
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Appendix F: Literature Review Matrix
Summary Table of Analyzed Articles
Citation (in APA style Conceptual
with doi or link)
Framework /
Theory

Main finding

Research
method /
Sample size /

Strengths of
the study

Weaknesses
of the study

Level of
Evidence

Guyatt, G. H. (1993).
Not identified
Measurement of health- /not used
related quality of life in
heart failure. Journal of
American College of
Cardiology, 22(4 Suppl
A), 185A-191A.

Only MLHFQ
showed diseasespecific
responsiveness
in context of
clinical trials.

Descriptive
method
utilized. No
sample size
identified.

Description of
generic and
specific
approaches to
measuring
quality of life
were outlined.
An example of
diseasespecific
measures in
heart failure
was provided.

Comparison of VI
different
questionnaires
based only on
outcomes of
single studies.

Guyatt, G. H. (1995). A Not identified
taxonomy of health
/not used
status instruments.
Journal of
Rheumatology, 22(6),
1188-1190.

Health related
quality of life
questionnaires
should be used
to inform care
and guide
policy
development.
There are

Descriptive
method
utilized. No
sample size
identified.

A taxonomy of
different
instruments
was listed—
generic and
specific-which
provided the
reader with

Listing of all
of the
available
instruments
but no
comparison
between the
instruments.

VII
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generic
instruments and
specific
instruments—
each has
strengths and
weakness.
Depending on
the focus, one
may be better
over the other.

Berry, C., &
McMurray, J. (1999).
A review of quality-oflife evaluations in
patients with
congestive heart
failure.
Pharmacoeconomics,
16(3), 247-271.

Not identified
/not used

Best diseasespecific QOL
questionnaires
are the MLHFQ
and the CHFQ.

options as to
what is
available.

Review of the
design and
validation
process of
generic and
disease
specific
quality of life
(QOL)
questionnaires.

Detailed
description of
the various
elements
measuring the
instruments’
validity and
ability to
discriminate
between
changing
levels of
severity of the
disease.

Conclusions
were drawn
based on
results of
single studies
only.

VI

90
Eurich, D. T., Johnson, Not identified
J. A., Reid, K. J., &
/not used
Spertus, J. A. (2006).
Assessing
responsiveness of
generic and specific
health related quality of
life measures in heart
failure. Health and
Quality of Life
Outcomes, 4(89).
http://doi.org/10.1186/1
477-7525-4-89

KCCQ was the
most responsive
health quality of
life
questionnaire to
assess change
over a 6-week
period of time

Cohort study
design with
sample size of
298 subjects
with heart
failure. Three
different
questionnaires
were
administered
and patients’
change was
measured
using three
external
indicators.

Subjects were
recruited from
14 medical
centers across
Canada and
the United
States (allows
for
generalizabilit
y)

Some of the
VI
external
indicators used
to measure
change are
subjective
(NYHA class).
Small sample
size.
Unclear as to
sampling
method:
possible
sampling bias?

Garin, O., Ferrer, M.,
Pont, A., Rue, M.,
Kotzeva, A., Van
Ganse, E., & Alonso, J.
(2009). Diseasespecific health-related
quality of life
questionnaires for heart
failure: A systematic
review with metaanalyses. Quality of
Life Research, 18(1),
71-85. http://

Evidence
showed that the
MLHFQ was
most reliable,
valid, and
responsive tool
among those
tested, followed
by the KCCQ,
then CHFQ.

Systematic
review with
meta-analysis.
Full text
reviews were
performed on
421 studies.

High level of
evidence and
large sample
size.
The study
tested for the
most
important/desir
able
components in
a clinical tool:
reliability,
validity, and

Did not
I
address the
administrative
burden on the
patients when
completing the
questionnaires.
Study did not
identify the
effect of the
different
settings
(hospital,

Not identified
/not used
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-008-9416-4

responsiveness
.

clinic, etc.).

Garin, O., Ferer, M.,
Not identified
Pont, A., Wiklund, I.,
/not used
Van Ganse, E., Vilagut,
G., …Alonso, J.
(2013). Evidence on
the global measurement
model of the Minnesota
Living with Heart
Failure Questionnaire.
Quality of Life
Research, 22(1), 26752684. http://
doi.org/10.1007/s11136
-013-0383-z

The total
MLFHQ score
was the most
commonly used
score in heart
failure patients.

Merged data
from eight
studies and 21
countries.
Sample size:
3847 patients.

The reliability
and validity of
the MLHFQ
was shown to
be consistent
among
different
countries.

The
effectiveness
of the
instruments
was evaluated
using different
criteria/
elements
among the
different
countries.

VI

Garin, O., Herdman,
Not identified
M., Vilagut, G., Ferre,
/not used
M., Ribera, A., Rajmil,
L., …Alonso, J. (2014).
Assessing healthrelated quality of life in
patients with heart
failure: A systematic,
standardized
comparison of
available measures.
Heart Failure Reviews,

The instruments
identified as
best with
respect to
reliability,
validity,
sensitivity, and
interpretability
were: KCCQ
and MLHFQ.

Systematic
review of all
of the
available
health-related
quality of life
instruments.
Seven tools
were identified
specifically for
heart failure.

Each of the
heart failure
questionnaires
were evaluated
based on
several
different
aspects such
as: validity,
sensitivity,
reliability, and
interpretability

None
identified.
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19(3), 359-367. http://
doi.org/10.1007/s10741
-013-9394-7
Kelkar, A. A., Spertus,
J., Pang, P., Pierson, R.
F., Cody, R. J., Pina, I.
L., …Butler, J. (2016).
Utility of patientreported outcome
instruments in heart
failure. Journal of
American College of
Cardiology, 4(3), 165175. http://
doi.org/10.1016/j.jchf.2
015.10.015

Not identified
/not used

Only two
patient-reported
outcome (PRO)
instruments for
heart failure
met the study
evaluation
criteria: KCCQ
and MLHFQ.

A systematic
review of
research
studies that
measured PRO
instruments in
heart failure.
31 instruments
were
identified, and
nine met all
inclusion
criteria, and
two met all
evaluation
criteria.

The study used
detailed
criteria for
measuring the
properties of
the PROs.

The study did I
not examine
the efficiency
of
implementing
/administering
these
questionnaires.
Therefore,
unable to
evaluate
feasibility of
applying these
instruments in
clinical
practice of
varying
settings.

Gilbert, A., SebagMontefiore, D.,
Davidson, S., &
Velikova, G. (2015).
Use of patient-reported
outcomes to measure
symptoms and health

Not identified
/not used

Clinical care
may benefit
from integration
of
patientreportedoutcomes

Review of
other articles
utilizing
patientreportedoutcomes
(PROs). No

The benefits of
using PROs
are identified,
including
frequency and
timing of
administration.

Not a
IV
systematic
review of data.
Only case
studies
presented.

93
related quality of life in
the clinic. Gynecologic
Oncology, 136(2015),
429-439. http://
doi.org/10.1016/j.ygyn
o.2014.11.071

(PROs)
instruments in
assessments.

sample size
available, no
method
identified.

The best
methods of
collecting this
data is
proposed.

Spertus, J. A., &
Nassif, M. E. (2016).
Screening health
questionnaires and
patient-reported
outcomes: Will
shortened versions
overcome the barriers
to their
implementation.
Journal of Cardiac
Failure, 22(2),
1080109. http://
doi.org/10.1016/j.cardf
ail.2015.11.010

Not identified
/not used

Shortened
versions of
screening
instruments
may underreport or underrecognize
significance of
symptoms.

No specific
method or
sample size
identified.

Highlights the
importance of
inclusive
assessment of
all aspect/
components of
the patient’s
status
including
cognitive
status.

Opinion only.
No specific
data was
presented.

VII

Psotka, M. A., von
Maltzahn, R.,
Anatchkova, M.,
Agodoa, I., Chau, D.,
Malik, F. I., …
Teerlink, J. R. (2016).
Patient-reported

Not identified
/not used

None of the
chronic heart
failure patientreported
outcome (PRO)
instruments met
the FDA

A systematic
literature
review of all
of the
available
articles
identifying the

Exhaustive
literature
review of all
available
articles over
the span of
five years

Only the
PROs that met
the FDA
recommended
guidelines
were reviewed
and analyzed.

I

94
outcomes in chronic
heart failure:
Applicability for
regulatory approval.
Journal of American
Colleges of Cardiology,
4(10), 791-804. http://
doi.org/10.1016/j.jchf.2
016.04.010

recommended
guidelines.

use of PROs.
2,552 articles
and 2,334
abstracts were
identified. 19
were chosen
for review.

(inclusiveness).

Heidenreich, P. A.,
Not
Spertus, J. A., Jones, P. identified/not
G., Weintraub, W. S.,
used
Rumsfeld, J. S.,
Rathore, S. S.,
…Williams, R. E.
(2006). Health status
identifies heart failure
outpatients at risk for
hospitalization or
death. Journal of
American College of
Cardiology, 47(7), 752756. http://
doi.org/10.1016/j.jacc.2
005.11.021

A low score
obtained on
Kansas City
Cardiomyopathy
Questionnaire
(KCCQ) was
association with
a poor
prognosis for
patients with
heart failure.

The sample
size consisted
of 505 patients
with heart
failure, from
13 outpatient
clinics.
Consecutive
patients who
met the study
criteria were
included
(ejection
fraction
<40%).

The sensitivity
of a tool
(independent
of other
clinical data)
was utilized to
predict heart
failure
prognosis.

Only one
III
questionnaire
was used
(KCCQ) to
evaluate for
predictors of
prognosis
independent of
other clinical
data.
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Appendix G: Levels of Evidence
Level of
Evidence
I
II
III

Description
Evidence from a systematic review or meta-analysis of all relevant
RCTs
Evidence obtained from well-designed RTC.

IV

Evidence obtained from well-designed controlled trials without
randomization
Evidence from well-designed case-control and cohort studies

V

Evidence from systematic reviews of descriptive and qualitative studies

VI

Evidence from single descriptive or qualitative studies

VII

Evidence from the opinion of authorities and/or reports of expert
committees

Ackley, B. J., Swan, B. A., Ladwig, G., & Tucker, S. (2008). Evidence-based nursing
care guidelines: Medical-surgical interventions. (p. 7). St. Louis, MO: Mosby Elsevier.
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Appendix I: IRB Approval
From: IRB <irb@mail.waldenu.edu>
Sent: Friday, May 26, 2017 4:54 PM
To: Lucy Paul
Cc: Patrick A. Palmieri
Subject: IRB Materials Approved - Lucy Paul

Dear Ms. Paul,
This email is to notify you that the Institutional Review Board (IRB) confirms that
your study entitled, "Heart Failure Screening Tools: Assessment for an
Outpatient Arrhythmia Devices Clinic," meets Walden University’s ethical
standards. Our records indicate that you will be analyzing data provided to you
by Hamilton Health Sciences as collected under its oversight. Since this study
will serve as a Walden doctoral capstone, the Walden IRB will oversee your
capstone data analysis and results reporting. The IRB approval number for this
study is 05-26-17-0542764.
This confirmation is contingent upon your adherence to the exact procedures
described in the final version of the documents that have been submitted
to IRB@mail.waldenu.edu as of this date. This includes maintaining your current
status with the university and the oversight relationship is only valid while you are
an actively enrolled student at Walden University. If you need to take a leave of
absence or are otherwise unable to remain actively enrolled, this is suspended.
If you need to make any changes to your research staff or procedures, you must
obtain IRB approval by submitting the IRB Request for Change in Procedures
Form. You will receive confirmation with a status update of the request within 1
week of submitting the change request form and are not permitted to implement
changes prior to receiving approval. Please note that Walden University does
not accept responsibility or liability for research activities conducted without the
IRB's approval, and the University will not accept or grant credit for student work
that fails to comply with the policies and procedures related to ethical standards
in research.
When you submitted your IRB materials, you made a commitment to
communicate both discrete adverse events and general problems to the IRB
within 1 week of their occurrence/realization. Failure to do so may result in
invalidation of data, loss of academic credit, and/or loss of legal protections
otherwise available to the researcher.
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Both the Adverse Event Reporting form and Request for Change in Procedures
form can be obtained at the IRB section of the Walden
website:http://academicguides.waldenu.edu/researchcenter/orec
Researchers are expected to keep detailed records of their research activities
(i.e., participant log sheets, completed consent forms, etc.) for the same period of
time they retain the original data. If, in the future, you require copies of the
originally submitted IRB materials, you may request them from Institutional
Review Board.
Both students and faculty are invited to provide feedback on this IRB experience
at the link below:
http://www.surveymonkey.com/s.aspx?sm=qHBJzkJMUx43pZegKlmdiQ_3d
_3d
Sincerely,
Libby Munson
Research Ethics Support Specialist
Office of Research Ethics and Compliance
Walden University
100 Washington Avenue South, Suite 900
Minneapolis, MN 55401
Email: irb@mail.waldenu.edu
Phone: (612) 312-1283
Fax: (626) 605-0472
Information about the Walden University Institutional Review Board, including
instructions for application, may be found at this
link:http://academicguides.waldenu.edu/researchcenter/orec
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Appendix J: Comparison Between Heart Failure Screening Groups
1. SHEFS, MLHFQ and KCCQ compared to BNP:
Percentage

Numbers
BNP
Yes
SHEFS

MLHFQ

KCCQ

BNP
No

Yes

Yes

5

1

6

No

1

8

9

6

9

15

Yes

2

0

2

No

4

9

13

6

9

15

Yes

3

1

4

No

3

8

11

6

9

15

No

83.3%

Sensitivity
88.9%

33.3%

Specificity
Sensitivity

100.0%
50.0%

Specificity
Sensitivity

88.9%

Specificity

Chi square comparison: p < 0.001
2. SHEFS compared to MLHFQ:
Percentage

Numbers

BNP

MLHFQ
Yes
No
SHEFS

Yes

Yes

5

13

18

No

2

35

37

7

48

55

No

71.4%

Sensitivity
72.9%

Specificity

Chi square comparison: p < 0.001
3. SHEFS compared to KCCQ:
Percentage

Numbers

BNP

KCCQ
Yes
No
SHEFS

Yes

Yes

6

12

18

No

2

35

37

8

47

55

Chi square comparison: p < 0.001

No

75.0%

Sensitivity
74.5%

Specificity

100
4. Univariate regression analysis of SHEFS, KCCQ, MLHFQ and BNP, and admission to
hospital in last 6 months
Dependent variable = Admission to hospital
p value
SHEFS

0.023

MLHFQ

0.030

KCCQ

0.025

BNP

0.310
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Appendix K: Decision Tree for Follow Up of Positive Screening Results

